ANRO Competitors & Alternatives
Compare Alto Neuroscience, Inc. with similar stocks in the same industry
Biotechnology
ANRO
Main Stock$28.61
Tradestie Score
41
Market Cap
$110.20M
Analyst Upside
+35.2%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$51.20
|
$1.17B | - | 33 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$19.08
|
$1.15B | 8.1 | 35 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$14.91
|
$1.14B | - | 35 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.91
|
$1.14B | - | 72 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$35.45
|
$1.13B | - | 44 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.41
|
$1.12B | - | 43 | Compare |
|
NKTR
Nektar Therapeutics
|
$37.78
|
$1.12B | - | 66 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$337.59
|
$1.12B | - | 36 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$6.42
|
$1.09B | - | 44 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.22
|
$1.05B | 41.1 | 23 | Compare |
More ANRO Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry